Fas, Fas ligand, and transfusion immunomodulation

被引：25

作者：

Puppo, F

Ghio, M

Contini, P

Mazzei, C

Indiveri, F

机构：

[1] Univ Genoa, Dept Internal Med, Div Internal Med & Clin Immunol, I-16126 Genoa, Italy

[2] Imperia Hosp, Blood Bank, Imperia, Italy

来源：

TRANSFUSION | 2001年 / 41卷 / 03期

关键词：

D O I：

10.1046/j.1537-2995.2001.41030416.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：416 / 418

页数：3

共 19 条

[1]

Blajchman M A, 1994, Curr Opin Hematol, V1, P457

[2] Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet? [J].

Blajchman, MA .

TRANSFUSION, 1997, 37 (02) :121-125

[3] SOLUBLE CD4, CD8, AND HLA MOLECULES IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS [J].

BLASCZYK, R ;

WESTHOFF, U ;

GROSSEWILDE, H .

LANCET, 1993, 341 (8848) :789-790

[4] Current research on the immunomodulatory effect of allogeneic blood transfusion [J].

Dzik, S ;

Blajchman, MA ;

Blumberg, N ;

Kirkley, SA ;

Heal, JM ;

Wood, K .

VOX SANGUINIS, 1996, 70 (04) :187-194

[5] Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J].

Fournel, S ;

Aguerre-Girr, M ;

Huc, X ;

Lenfant, F ;

Alam, A ;

Toubert, A ;

Bensussan, A ;

Le Bouteiller, P .

JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6100-6104

[6] Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions [J].

Ghio, M ;

Contini, P ;

Mazzei, C ;

Brenci, S ;

Barberis, G ;

Filaci, G ;

Indiveri, F ;

Puppo, F .

BLOOD, 1999, 93 (05) :1770-1777

[7] SOLUBLE HLA CLASS-I AND CLASS-II CONCENTRATIONS IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS [J].

GROSSEWILDE, H ;

BLASCZYK, R ;

WESTHOFF, U .

TISSUE ANTIGENS, 1992, 39 (02) :74-77

[8] Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils [J].

Liles, WC ;

Kiener, PA ;

Ledbetter, JA ;

Aruffo, A ;

Klebanoff, SJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :429-440

[9]

Martínez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274

[10] FAS AND FAS LIGAND - LPR AND GLD MUTATIONS [J].

NAGATA, S ;

SUDA, T .

IMMUNOLOGY TODAY, 1995, 16 (01) :39-43

← 1 2 →